Wesper Journal

Wesper is poised to change sleep medicine alongside GLP-1 by integrating advanced sleep monitoring technology with GLP-1 therapies, enabling comprehensive and personalized treatment for sleep apnea. This combination offers real-time treatment optimization and enhanced patient outcomes, marking a significant advancement...

Many people experience immediate mental clarity and reduced brain fog after just one night of using CPAP therapy, as it alleviates airway obstruction and enhances sleep quality. The therapy delivers consistent airway support, leading to improved oxygen levels and restorative...

Subclinical sleep apnea represents the often-overlooked middle ground between benign snoring and clinically diagnosed obstructive sleep apnea (OSA). Though these patients may not meet the standard AHI ≥ 5 threshold, they frequently experience measurable physiological disruptions — including flow-limited breathing, mild oxygen desaturations, and fragmented sleep. These subtle patterns contribute to increased cardiovascular strain, metabolic dysregulation, and cognitive impairment long before overt disease appears. Traditional single-night polysomnography often misses these early deviations, leaving at-risk patients undiagnosed until symptoms or comorbidities worsen. Advancements in medical-grade home sleep testing (HSAT) are changing that trajectory. By capturing true respiratory effort, oxygenation, and positional data across multiple nights in the patient’s natural environment, systems like Wesper’s allow clinicians to detect the earliest signs of airway instability and hypoxic burden. This longitudinal insight enables proactive intervention — through lifestyle changes, airway optimization, or targeted therapy — before OSA becomes entrenched. As Dr. Chelsie Rohrscheib, PhD, notes, medical-grade HSAT redefines the future of sleep medicine by shifting care from reactive diagnosis to preventive precision.